Cargando…
EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
The main aim of health technology assessment (HTA) is to inform decision making by health care policy makers. It is a systematic process that evaluates the use of health technologies and generally involves a critical review of international evidence related to clinical effectiveness of the health te...
Autores principales: | Hunter, Amy, Facey, Karen, Thomas, Victoria, Haerry, David, Warner, Kay, Klingmann, Ingrid, May, Matthew, See, Wolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136274/ https://www.ncbi.nlm.nih.gov/pubmed/30238004 http://dx.doi.org/10.3389/fmed.2018.00231 |
Ejemplares similares
-
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
por: Haerry, David, et al.
Publicado: (2018) -
EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D
por: Warner, Kay, et al.
Publicado: (2018) -
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
por: Klingmann, Ingrid, et al.
Publicado: (2018) -
The Role of EUPATI CH in Promoting Patient Involvement in Clinical Research: A Multi-Stakeholder Research Project
por: Sessa, Cristiana, et al.
Publicado: (2021) -
Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey
por: Grine, Lynda, et al.
Publicado: (2020)